Velarion · Company Intelligence
Compensation Brief
Fiscal year 2025 · Filings through 2026-10-16

GILEAD SCIENCES, INC. (GILD)

CEO Daniel O'Day was paid $28,437,198 in fiscal year 2025, ↑ up 20.0% from fiscal year 2024, the 70th percentile of its disclosed peer group (SEC filing 0001308179-26-000106 ↗): executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.

$28,437,198 ↑
Daniel O'Day total, FY2025
70th
CEO pay percentile vs peers
119:1
CEO-to-median pay ratio
92.19%
Say-on-pay support, latest vote

Track this company's pay every filing: join the Pro seat waitlist

Velarion Pro: every company page, peer tools and exports, one seat — $1,200/year

A confirmation now and one email when Pro opens, and nothing else. Privacy

Ask our research desk — $99, 24h, every figure cited to its filing.

Sample answer — “What is the CEO’s total compensation?”
- Daniel O'Day (Chairman and Chief Executive Officer), FY2025 total compensation $28,437,198 (base salary $1,795,192) [exec_comp, SEC accession 0001308179-26-000106, filed 2026-03-20]

Answered within 24 hours, every figure cited to its SEC filing. If our database cannot answer your question, you are refunded automatically.

GILD's next annual pay disclosure, estimated March 13, 2027.est. Filing ↗

01

Summary Compensation Table — fiscal year 2025

Named executive officerSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
Daniel O'Day$1,795,192$0$15,238,402$4,500,060$4,848,120$0$2,055,424$28,437,198
Chairman and Chief Executive Officer
Dietmar Berger969,2313,000,0006,999,7581,000,0431,603,5940350,25213,922,878
Chief Medical Officer
Johanna Mercier1,182,26904,564,5171,299,9762,150,9010102,9809,300,643
Chief Commercial and Corporate Affairs Officer
Andrew Dickinson1,116,65404,321,7411,299,9761,956,266070,9798,765,616
Chief Financial Officer
Deborah Telman977,33403,071,792900,0650055,4785,004,669
Former Executive Vice President, Corporate Affairs and General Counsel

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.

Three-year trend — total compensation per named executive

Named executive officerFY2025 totalFY2024 totalFY2023 totalΔ FY2024→2025
Daniel O'Day$28,437,198$23,689,392$22,607,690↑ +4,747,806
Dietmar Berger13,922,878———
Johanna Mercier9,300,6438,609,0658,586,754↑ +691,578
Andrew Dickinson8,765,6168,109,7588,107,823↑ +655,858
Deborah Telman5,004,6696,071,879—↓ −1,067,210

Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.

You have just read GILEAD SCIENCES, INC.'s Summary Compensation Table. The whole free brief as a PDF, emailed now, with every figure cited — then a few short notes on the deeper GILD reports.

We send the PDF right away, then up to three short notes. Reply “unsubscribe” to any of them, any time.

Get the GILEAD SCIENCES, INC. Peer Teardown Report

$28,437,198 Daniel O'Day total, FY2025

$199

The free page is the headline. The teardown reads every company in the disclosed peer group on its own numbers.

Data as of October 16, 2026 · Source: 0001308179-26-000106 · Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

Reports for GILD

Every report below is generated from the same filings as the free brief above, at the moment of purchase. What each one adds:

Executive Compensation ReportThe free page is the headline figures. The report is every award, peer and vote combined into one document you can hand to a committee.$1,500 →Reverse Peer AnalysisThe free page is the one line. The analysis reads every company that names this one in its own peer group.$299 →Peer Teardown ReportThe free page is the headline. The teardown reads every company in the disclosed peer group on its own numbers.$199 →
GILDon Velarion Intel, free → The platform reading of this company, beside the same data as a subscription.

Order GILD

Pick the report, add the email the receipt and the PDF go to, and pay by card on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

How we handle your data → Privacy

Companies that benchmark against GILD
27 companies name GILD as a compensation peer

The list of companies that name GILD as a peer is temporarily unavailable — recheck shortly.

Get the GILEAD SCIENCES, INC. Executive Compensation Report

$1,500

Buy the report - $1,500Both reports - $2,400
01b

Executives — the named officers

One page per officer: the same table above, read for one person at a time — his own figure and every fiscal year the register holds.

ExecutiveRoleFY2025 total
Daniel O'DayCEO$28,437,198
Dietmar BergerChief Medical Officer$13,922,878
Johanna MercierExecutive$9,300,643
Andrew DickinsonCFO$8,765,616
Deborah TelmanGeneral Counsel$5,004,669
01c

Board of directors

One page per director: the seat, the committees and the fee table, read for one person at a time.

DirectorRoleFY2025 total
Anthony WeltersLead Independent Director$479,962
Harish M. ManwaniIndependent Director$432,442
Jacqueline K. BartonIndependent Director$429,921
Javier J. RodriguezIndependent Director$409,921
Jeffrey A. BluestoneIndependent Director$409,781
Kelly A. KramerIndependent Director$437,442
Sandra J. HorningIndependent Director$433,942
Ted W. LoveIndependent Director$409,921
02

Equity transactions since the proxy statement was filed

Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.

InsiderRoleTransaction dateCodeSharesPriceValueSecuritySource
Daniel Patrick O'DayDirector2026-03-27D10,000$137$1,368,162CommonForm 4 ↗
Johanna MercierChief Comm & Corp Aff Officer2026-04-15D3,000141422,880CommonForm 4 ↗
Andrew DickinsonChief Financial Officer2026-04-15D3,000141422,880CommonForm 4 ↗
Daniel Patrick O'DayDirector2026-04-28D3,050130396,534CommonForm 4 ↗
Daniel Patrick O'DayDirector2026-04-28D6,950129895,075CommonForm 4 ↗
Harish M. ManwaniDirector2026-04-30D22413129,308CommonForm 4 ↗
Kelly A. KramerDirector2026-04-30A4,88400Derivative, Class A CommonForm 4 ↗
Dividend-equivalent accruals2026-04-30—1,146——1 insider, 1 accrual row
Harish M. ManwaniDirector2026-04-30A4,88400Derivative, Class A CommonForm 4 ↗
Harish M. ManwaniDirector2026-04-30A1,14600CommonForm 4 ↗
Anthony WeltersDirector2026-04-30A4,88400Derivative, Class A CommonForm 4 ↗
Anthony WeltersDirector2026-04-30A1,14600CommonForm 4 ↗
Javier J. RodriguezDirector2026-04-30A1,14600CommonForm 4 ↗
Ted W. LoveDirector2026-04-30A1,14600CommonForm 4 ↗
Sandra J. HorningDirector2026-04-30A4,88400Derivative, Class A CommonForm 4 ↗
Sandra J. HorningDirector2026-04-30A1,14600CommonForm 4 ↗
Jacqueline K. BartonDirector2026-04-30A4,88400Derivative, Class A CommonForm 4 ↗
Jeffrey A. BluestoneDirector2026-04-30A4,88400Derivative, Class A CommonForm 4 ↗
Jeffrey A. BluestoneDirector2026-04-30A1,14600CommonForm 4 ↗
Javier J. RodriguezDirector2026-04-30A4,88400Derivative, Class A CommonForm 4 ↗
Ted W. LoveDirector2026-04-30A4,88400Derivative, Class A CommonForm 4 ↗
Jacqueline K. BartonDirector2026-04-30A1,14600CommonForm 4 ↗
Johanna MercierChief Comm & Corp Aff Officer2026-05-15D25,00000Derivative, Class A CommonForm 4 ↗
Johanna MercierChief Comm & Corp Aff Officer2026-05-15D70013392,926CommonForm 4 ↗
Johanna MercierChief Comm & Corp Aff Officer2026-05-15D8,3741321,107,314CommonForm 4 ↗
Johanna MercierChief Comm & Corp Aff Officer2026-05-15D11,1771311,466,330CommonForm 4 ↗
Johanna MercierChief Comm & Corp Aff Officer2026-05-15D7,7491301,009,629CommonForm 4 ↗
Johanna MercierChief Comm & Corp Aff Officer2026-05-15A25,000671,666,000CommonForm 4 ↗
Andrew DickinsonChief Financial Officer2026-05-15D3,000132396,810CommonForm 4 ↗
Daniel Patrick O'DayDirector2026-06-01D3,062132404,843CommonForm 4 ↗
Daniel Patrick O'DayDirector2026-06-01D10,9001311,428,983CommonForm 4 ↗
Daniel Patrick O'DayDirector2026-06-01D1,038133138,021CommonForm 4 ↗
Daniel Patrick O'DayDirector2026-06-10D8,779——Derivative, Class A CommonForm 4 ↗
Daniel Patrick O'DayDirector2026-06-10D4,213121511,795CommonForm 4 ↗
Daniel Patrick O'DayDirector2026-06-10A8,779——CommonForm 4 ↗
Johanna MercierChief Comm & Corp Aff Officer2026-06-10D2,796——Derivative, Class A CommonForm 4 ↗
Andrew DickinsonChief Financial Officer2026-06-10D2,796——Derivative, Class A CommonForm 4 ↗
Andrew DickinsonChief Financial Officer2026-06-10A2,796——CommonForm 4 ↗
Cain Wettan Keeley MEVP Gen Counsel, Legal & Comp2026-06-10D589——Derivative, Class A CommonForm 4 ↗
Cain Wettan Keeley MEVP Gen Counsel, Legal & Comp2026-06-10A589——CommonForm 4 ↗
Dietmar BergerChief Medical Officer2026-06-10D533——Derivative, Class A CommonForm 4 ↗
Dietmar BergerChief Medical Officer2026-06-10D26312131,949CommonForm 4 ↗
Dietmar BergerChief Medical Officer2026-06-10A533——CommonForm 4 ↗
Johanna MercierChief Comm & Corp Aff Officer2026-06-10A2,796——CommonForm 4 ↗
Andrew DickinsonChief Financial Officer2026-06-10D1,341121162,905CommonForm 4 ↗
Cain Wettan Keeley MEVP Gen Counsel, Legal & Comp2026-06-10D28312134,379CommonForm 4 ↗
Johanna MercierChief Comm & Corp Aff Officer2026-06-10D1,341121162,905CommonForm 4 ↗
Andrew DickinsonChief Financial Officer2026-06-15D3,000125376,200CommonForm 4 ↗
Johanna MercierChief Comm & Corp Aff Officer2026-06-15D45012556,430CommonForm 4 ↗
Johanna MercierChief Comm & Corp Aff Officer2026-06-15D1,070124132,676CommonForm 4 ↗
Johanna MercierChief Comm & Corp Aff Officer2026-06-15D1,480123182,657CommonForm 4 ↗
Daniel Patrick O'DayDirector2026-07-01D3,100127393,933CommonForm 4 ↗
Daniel Patrick O'DayDirector2026-07-01D11,9001261,500,467CommonForm 4 ↗
Johanna MercierChief Comm & Corp Aff Officer2026-07-15D3,000130389,758CommonForm 4 ↗
Andrew DickinsonChief Financial Officer2026-07-15D3,000130389,777CommonForm 4 ↗
Daniel Patrick O'DayDirector2026-08-03D7,7001311,007,177CommonForm 4 ↗
Daniel Patrick O'DayDirector2026-08-03D6,700130868,711CommonForm 4 ↗
Daniel Patrick O'DayDirector2026-08-03D60013178,806CommonForm 4 ↗
Cain Wettan Keeley MEVP Gen Counsel, Legal & Comp2026-08-10D6,002——Derivative, Class A CommonForm 4 ↗
Cain Wettan Keeley MEVP Gen Counsel, Legal & Comp2026-08-10A6,002——CommonForm 4 ↗
Cain Wettan Keeley MEVP Gen Counsel, Legal & Comp2026-08-10D2,908133386,938CommonForm 4 ↗
Johanna MercierChief Comm & Corp Aff Officer2026-08-17D23,11000Derivative, Class A CommonForm 4 ↗
Johanna MercierChief Comm & Corp Aff Officer2026-08-17D11,4701381,583,265CommonForm 4 ↗
Johanna MercierChief Comm & Corp Aff Officer2026-08-17D16,5301372,270,643CommonForm 4 ↗
Johanna MercierChief Comm & Corp Aff Officer2026-08-17A1,89072136,723CommonForm 4 ↗
Andrew DickinsonChief Financial Officer2026-08-17D3,000138415,080CommonForm 4 ↗
Dividend-equivalent accruals2026-08-17—1,890——1 insider, 1 accrual row
Johanna MercierChief Comm & Corp Aff Officer2026-08-17A23,110671,540,050CommonForm 4 ↗
Dividend-equivalent accruals2026-08-20—335——1 insider, 1 accrual row
Jeffrey A. BluestoneDirector2026-08-20D4,66500Derivative, Class A CommonForm 4 ↗
Jeffrey A. BluestoneDirector2026-08-20A3356120,552CommonForm 4 ↗
Jeffrey A. BluestoneDirector2026-08-20D261463,805CommonForm 4 ↗
Jeffrey A. BluestoneDirector2026-08-20A1,65867111,832CommonForm 4 ↗
Jeffrey A. BluestoneDirector2026-08-20A26671,754CommonForm 4 ↗
Jeffrey A. BluestoneDirector2026-08-20D1,658146241,618CommonForm 4 ↗
Jeffrey A. BluestoneDirector2026-08-20A1,81667122,489CommonForm 4 ↗
Jeffrey A. BluestoneDirector2026-08-20A1,1656778,579CommonForm 4 ↗
Jeffrey A. BluestoneDirector2026-08-20D33514648,997CommonForm 4 ↗
Jeffrey A. BluestoneDirector2026-08-20D1,165144167,474CommonForm 4 ↗
Jeffrey A. BluestoneDirector2026-08-20D1,816145263,183CommonForm 4 ↗
Anthony WeltersDirector2026-08-26D10,28200Derivative, Class A CommonForm 4 ↗
Anthony WeltersDirector2026-08-26D7,71800Derivative, Class A CommonForm 4 ↗
Anthony WeltersDirector2026-08-26D6,8801491,023,900CommonForm 4 ↗
Anthony WeltersDirector2026-08-26D3,402148504,296CommonForm 4 ↗
Anthony WeltersDirector2026-08-26A10,28261630,801CommonForm 4 ↗
Anthony WeltersDirector2026-08-26D3,118148462,432CommonForm 4 ↗
Anthony WeltersDirector2026-08-26A7,71861468,251CommonForm 4 ↗
Anthony WeltersDirector2026-08-26D4,600149684,590CommonForm 4 ↗
Daniel Patrick O'DayDirector2026-09-01D5,408149807,856CommonForm 4 ↗
Daniel Patrick O'DayDirector2026-09-01D7,9921481,185,722CommonForm 4 ↗
Daniel Patrick O'DayDirector2026-09-01D1,600148236,014CommonForm 4 ↗
Daniel Patrick O'DayDirector2026-09-10D8,780——Derivative, Class A CommonForm 4 ↗
Daniel Patrick O'DayDirector2026-09-10D4,230145612,546CommonForm 4 ↗
Daniel Patrick O'DayDirector2026-09-10A8,780——CommonForm 4 ↗
Cain Wettan Keeley MEVP Gen Counsel, Legal & Comp2026-09-10D590——Derivative, Class A CommonForm 4 ↗
Cain Wettan Keeley MEVP Gen Counsel, Legal & Comp2026-09-10A590——CommonForm 4 ↗
Johanna MercierChief Comm & Corp Aff Officer2026-09-10D2,797——Derivative, Class A CommonForm 4 ↗
Johanna MercierChief Comm & Corp Aff Officer2026-09-10D1,347145195,059CommonForm 4 ↗
Johanna MercierChief Comm & Corp Aff Officer2026-09-10A2,797——CommonForm 4 ↗
Dietmar BergerChief Medical Officer2026-09-10D533——Derivative, Class A CommonForm 4 ↗
Dietmar BergerChief Medical Officer2026-09-10A533——CommonForm 4 ↗
Andrew DickinsonChief Financial Officer2026-09-10D2,797——Derivative, Class A CommonForm 4 ↗
Dietmar BergerChief Medical Officer2026-09-10D26314538,085CommonForm 4 ↗
Andrew DickinsonChief Financial Officer2026-09-10D1,347145195,059CommonForm 4 ↗
Andrew DickinsonChief Financial Officer2026-09-10A2,797——CommonForm 4 ↗
Cain Wettan Keeley MEVP Gen Counsel, Legal & Comp2026-09-10D28514541,271CommonForm 4 ↗
Johanna MercierChief Comm & Corp Aff Officer2026-09-15D60014587,174CommonForm 4 ↗
Johanna MercierChief Comm & Corp Aff Officer2026-09-15D800144115,566CommonForm 4 ↗
Andrew DickinsonChief Financial Officer2026-09-15D3,000145435,870CommonForm 4 ↗
Johanna MercierChief Comm & Corp Aff Officer2026-09-15D1,600144229,907CommonForm 4 ↗
Erin BurkhartSVP, Controllership2026-09-22D2,223——Derivative, Class A CommonForm 4 ↗
Erin BurkhartSVP, Controllership2026-09-22A2,223——CommonForm 4 ↗
Erin BurkhartSVP, Controllership2026-09-22D768153117,251CommonForm 4 ↗
Daniel Patrick O'DayDirector2026-10-01D3,000149445,880CommonForm 4 ↗
Daniel Patrick O'DayDirector2026-10-01D12,0001481,772,628CommonForm 4 ↗
Andrew DickinsonChief Financial Officer2026-10-15D3,000156468,660CommonForm 4 ↗
Johanna MercierChief Comm & Corp Aff Officer2026-10-15D3,000156468,660CommonForm 4 ↗

Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.

View all 117 transactions
InsiderRoleTransaction dateCodeSharesPriceValueSecuritySource
Daniel Patrick O'DayDirector2026-03-27D10,000$137$1,368,162CommonForm 4 ↗
Johanna MercierChief Comm & Corp Aff Officer2026-04-15D3,000141422,880CommonForm 4 ↗
Andrew DickinsonChief Financial Officer2026-04-15D3,000141422,880CommonForm 4 ↗
Daniel Patrick O'DayDirector2026-04-28D3,050130396,534CommonForm 4 ↗
Daniel Patrick O'DayDirector2026-04-28D6,950129895,075CommonForm 4 ↗
Harish M. ManwaniDirector2026-04-30D22413129,308CommonForm 4 ↗
Kelly A. KramerDirector2026-04-30A4,88400Derivative, Class A CommonForm 4 ↗
Kelly A. KramerDirector2026-04-30A1,14600Derivative, Class A CommonForm 4 ↗
Harish M. ManwaniDirector2026-04-30A4,88400Derivative, Class A CommonForm 4 ↗
Harish M. ManwaniDirector2026-04-30A1,14600CommonForm 4 ↗
Anthony WeltersDirector2026-04-30A4,88400Derivative, Class A CommonForm 4 ↗
Anthony WeltersDirector2026-04-30A1,14600CommonForm 4 ↗
Javier J. RodriguezDirector2026-04-30A1,14600CommonForm 4 ↗
Ted W. LoveDirector2026-04-30A1,14600CommonForm 4 ↗
Sandra J. HorningDirector2026-04-30A4,88400Derivative, Class A CommonForm 4 ↗
Sandra J. HorningDirector2026-04-30A1,14600CommonForm 4 ↗
Jacqueline K. BartonDirector2026-04-30A4,88400Derivative, Class A CommonForm 4 ↗
Jeffrey A. BluestoneDirector2026-04-30A4,88400Derivative, Class A CommonForm 4 ↗
Jeffrey A. BluestoneDirector2026-04-30A1,14600CommonForm 4 ↗
Javier J. RodriguezDirector2026-04-30A4,88400Derivative, Class A CommonForm 4 ↗
Ted W. LoveDirector2026-04-30A4,88400Derivative, Class A CommonForm 4 ↗
Jacqueline K. BartonDirector2026-04-30A1,14600CommonForm 4 ↗
Johanna MercierChief Comm & Corp Aff Officer2026-05-15D25,00000Derivative, Class A CommonForm 4 ↗
Johanna MercierChief Comm & Corp Aff Officer2026-05-15D70013392,926CommonForm 4 ↗
Johanna MercierChief Comm & Corp Aff Officer2026-05-15D8,3741321,107,314CommonForm 4 ↗
Johanna MercierChief Comm & Corp Aff Officer2026-05-15D11,1771311,466,330CommonForm 4 ↗
Johanna MercierChief Comm & Corp Aff Officer2026-05-15D7,7491301,009,629CommonForm 4 ↗
Johanna MercierChief Comm & Corp Aff Officer2026-05-15A25,000671,666,000CommonForm 4 ↗
Andrew DickinsonChief Financial Officer2026-05-15D3,000132396,810CommonForm 4 ↗
Daniel Patrick O'DayDirector2026-06-01D3,062132404,843CommonForm 4 ↗
Daniel Patrick O'DayDirector2026-06-01D10,9001311,428,983CommonForm 4 ↗
Daniel Patrick O'DayDirector2026-06-01D1,038133138,021CommonForm 4 ↗
Daniel Patrick O'DayDirector2026-06-10D8,779——Derivative, Class A CommonForm 4 ↗
Daniel Patrick O'DayDirector2026-06-10D4,213121511,795CommonForm 4 ↗
Daniel Patrick O'DayDirector2026-06-10A8,779——CommonForm 4 ↗
Johanna MercierChief Comm & Corp Aff Officer2026-06-10D2,796——Derivative, Class A CommonForm 4 ↗
Andrew DickinsonChief Financial Officer2026-06-10D2,796——Derivative, Class A CommonForm 4 ↗
Andrew DickinsonChief Financial Officer2026-06-10A2,796——CommonForm 4 ↗
Cain Wettan Keeley MEVP Gen Counsel, Legal & Comp2026-06-10D589——Derivative, Class A CommonForm 4 ↗
Cain Wettan Keeley MEVP Gen Counsel, Legal & Comp2026-06-10A589——CommonForm 4 ↗
Dietmar BergerChief Medical Officer2026-06-10D533——Derivative, Class A CommonForm 4 ↗
Dietmar BergerChief Medical Officer2026-06-10D26312131,949CommonForm 4 ↗
Dietmar BergerChief Medical Officer2026-06-10A533——CommonForm 4 ↗
Johanna MercierChief Comm & Corp Aff Officer2026-06-10A2,796——CommonForm 4 ↗
Andrew DickinsonChief Financial Officer2026-06-10D1,341121162,905CommonForm 4 ↗
Cain Wettan Keeley MEVP Gen Counsel, Legal & Comp2026-06-10D28312134,379CommonForm 4 ↗
Johanna MercierChief Comm & Corp Aff Officer2026-06-10D1,341121162,905CommonForm 4 ↗
Andrew DickinsonChief Financial Officer2026-06-15D3,000125376,200CommonForm 4 ↗
Johanna MercierChief Comm & Corp Aff Officer2026-06-15D45012556,430CommonForm 4 ↗
Johanna MercierChief Comm & Corp Aff Officer2026-06-15D1,070124132,676CommonForm 4 ↗
Johanna MercierChief Comm & Corp Aff Officer2026-06-15D1,480123182,657CommonForm 4 ↗
Daniel Patrick O'DayDirector2026-07-01D3,100127393,933CommonForm 4 ↗
Daniel Patrick O'DayDirector2026-07-01D11,9001261,500,467CommonForm 4 ↗
Johanna MercierChief Comm & Corp Aff Officer2026-07-15D3,000130389,758CommonForm 4 ↗
Andrew DickinsonChief Financial Officer2026-07-15D3,000130389,777CommonForm 4 ↗
Daniel Patrick O'DayDirector2026-08-03D7,7001311,007,177CommonForm 4 ↗
Daniel Patrick O'DayDirector2026-08-03D6,700130868,711CommonForm 4 ↗
Daniel Patrick O'DayDirector2026-08-03D60013178,806CommonForm 4 ↗
Cain Wettan Keeley MEVP Gen Counsel, Legal & Comp2026-08-10D6,002——Derivative, Class A CommonForm 4 ↗
Cain Wettan Keeley MEVP Gen Counsel, Legal & Comp2026-08-10A6,002——CommonForm 4 ↗
Cain Wettan Keeley MEVP Gen Counsel, Legal & Comp2026-08-10D2,908133386,938CommonForm 4 ↗
Johanna MercierChief Comm & Corp Aff Officer2026-08-17D23,11000Derivative, Class A CommonForm 4 ↗
Johanna MercierChief Comm & Corp Aff Officer2026-08-17D11,4701381,583,265CommonForm 4 ↗
Johanna MercierChief Comm & Corp Aff Officer2026-08-17D16,5301372,270,643CommonForm 4 ↗
Johanna MercierChief Comm & Corp Aff Officer2026-08-17A1,89072136,723CommonForm 4 ↗
Andrew DickinsonChief Financial Officer2026-08-17D3,000138415,080CommonForm 4 ↗
Johanna MercierChief Comm & Corp Aff Officer2026-08-17D1,89000Derivative, Class A CommonForm 4 ↗
Johanna MercierChief Comm & Corp Aff Officer2026-08-17A23,110671,540,050CommonForm 4 ↗
Jeffrey A. BluestoneDirector2026-08-20D33500Derivative, Class A CommonForm 4 ↗
Jeffrey A. BluestoneDirector2026-08-20D4,66500Derivative, Class A CommonForm 4 ↗
Jeffrey A. BluestoneDirector2026-08-20A3356120,552CommonForm 4 ↗
Jeffrey A. BluestoneDirector2026-08-20D261463,805CommonForm 4 ↗
Jeffrey A. BluestoneDirector2026-08-20A1,65867111,832CommonForm 4 ↗
Jeffrey A. BluestoneDirector2026-08-20A26671,754CommonForm 4 ↗
Jeffrey A. BluestoneDirector2026-08-20D1,658146241,618CommonForm 4 ↗
Jeffrey A. BluestoneDirector2026-08-20A1,81667122,489CommonForm 4 ↗
Jeffrey A. BluestoneDirector2026-08-20A1,1656778,579CommonForm 4 ↗
Jeffrey A. BluestoneDirector2026-08-20D33514648,997CommonForm 4 ↗
Jeffrey A. BluestoneDirector2026-08-20D1,165144167,474CommonForm 4 ↗
Jeffrey A. BluestoneDirector2026-08-20D1,816145263,183CommonForm 4 ↗
Anthony WeltersDirector2026-08-26D10,28200Derivative, Class A CommonForm 4 ↗
Anthony WeltersDirector2026-08-26D7,71800Derivative, Class A CommonForm 4 ↗
Anthony WeltersDirector2026-08-26D6,8801491,023,900CommonForm 4 ↗
Anthony WeltersDirector2026-08-26D3,402148504,296CommonForm 4 ↗
Anthony WeltersDirector2026-08-26A10,28261630,801CommonForm 4 ↗
Anthony WeltersDirector2026-08-26D3,118148462,432CommonForm 4 ↗
Anthony WeltersDirector2026-08-26A7,71861468,251CommonForm 4 ↗
Anthony WeltersDirector2026-08-26D4,600149684,590CommonForm 4 ↗
Daniel Patrick O'DayDirector2026-09-01D5,408149807,856CommonForm 4 ↗
Daniel Patrick O'DayDirector2026-09-01D7,9921481,185,722CommonForm 4 ↗
Daniel Patrick O'DayDirector2026-09-01D1,600148236,014CommonForm 4 ↗
Daniel Patrick O'DayDirector2026-09-10D8,780——Derivative, Class A CommonForm 4 ↗
Daniel Patrick O'DayDirector2026-09-10D4,230145612,546CommonForm 4 ↗
Daniel Patrick O'DayDirector2026-09-10A8,780——CommonForm 4 ↗
Cain Wettan Keeley MEVP Gen Counsel, Legal & Comp2026-09-10D590——Derivative, Class A CommonForm 4 ↗
Cain Wettan Keeley MEVP Gen Counsel, Legal & Comp2026-09-10A590——CommonForm 4 ↗
Johanna MercierChief Comm & Corp Aff Officer2026-09-10D2,797——Derivative, Class A CommonForm 4 ↗
Johanna MercierChief Comm & Corp Aff Officer2026-09-10D1,347145195,059CommonForm 4 ↗
Johanna MercierChief Comm & Corp Aff Officer2026-09-10A2,797——CommonForm 4 ↗
Dietmar BergerChief Medical Officer2026-09-10D533——Derivative, Class A CommonForm 4 ↗
Dietmar BergerChief Medical Officer2026-09-10A533——CommonForm 4 ↗
Andrew DickinsonChief Financial Officer2026-09-10D2,797——Derivative, Class A CommonForm 4 ↗
Dietmar BergerChief Medical Officer2026-09-10D26314538,085CommonForm 4 ↗
Andrew DickinsonChief Financial Officer2026-09-10D1,347145195,059CommonForm 4 ↗
Andrew DickinsonChief Financial Officer2026-09-10A2,797——CommonForm 4 ↗
Cain Wettan Keeley MEVP Gen Counsel, Legal & Comp2026-09-10D28514541,271CommonForm 4 ↗
Johanna MercierChief Comm & Corp Aff Officer2026-09-15D60014587,174CommonForm 4 ↗
Johanna MercierChief Comm & Corp Aff Officer2026-09-15D800144115,566CommonForm 4 ↗
Andrew DickinsonChief Financial Officer2026-09-15D3,000145435,870CommonForm 4 ↗
Johanna MercierChief Comm & Corp Aff Officer2026-09-15D1,600144229,907CommonForm 4 ↗
Erin BurkhartSVP, Controllership2026-09-22D2,223——Derivative, Class A CommonForm 4 ↗
Erin BurkhartSVP, Controllership2026-09-22A2,223——CommonForm 4 ↗
Erin BurkhartSVP, Controllership2026-09-22D768153117,251CommonForm 4 ↗
Daniel Patrick O'DayDirector2026-10-01D3,000149445,880CommonForm 4 ↗
Daniel Patrick O'DayDirector2026-10-01D12,0001481,772,628CommonForm 4 ↗
Andrew DickinsonChief Financial Officer2026-10-15D3,000156468,660CommonForm 4 ↗
Johanna MercierChief Comm & Corp Aff Officer2026-10-15D3,000156468,660CommonForm 4 ↗
03

Grants of plan-based awards — fiscal year 2025

ExecutiveAwardGrant dateThresholdTargetGrantedMaximumGrant-date fair value
Johanna MercierPerformance Share2025-03-10————$676,067
Andrew DickinsonPerformance Share2025-03-10————638,795
Johanna MercierPerformance Share2025-03-10————1,949,796
Deborah TelmanPerformance Share2025-03-10————399,217
Deborah TelmanPerformance Share2025-03-10————422,542
Dietmar BergerPerformance Share2025-03-10————1,500,134
Dietmar BergerRSU2025-03-10——8,530—999,801
Deborah TelmanPerformance Share2025-03-10————1,349,860
Deborah TelmanRSU2025-03-10——7,680—900,173
Daniel O'DayPerformance Share2025-03-103,66118,303—36,6062,145,295
Dietmar BergerOPTION2025-03-10——37,710—1,000,043
Johanna MercierPerformance Share2025-03-10————638,795
Johanna MercierOPTION2025-03-10——49,020—1,299,976
Andrew DickinsonPerformance Share2025-03-10————1,949,796
Dietmar BergerRSU2025-01-02——48,975—4,499,823
Andrew DickinsonPerformance Share2025-03-10————433,292
Johanna MercierRSU2025-03-10——11,090—1,299,859
Daniel O'DayPerformance Share2025-03-109,60544,953—89,9066,749,937
Daniel O'DayRSU2025-03-10——38,395—4,500,278
Andrew DickinsonRSU2025-03-10——11,090—1,299,859
Daniel O'DayPerformance Share2025-03-103,14515,723—31,4461,842,893
Andrew DickinsonOPTION2025-03-10——49,020—1,299,976
Deborah TelmanOPTION2025-03-10——33,940—900,065
Daniel O'DayOPTION2025-03-10——169,690—4,500,060
03b

Vehicle mix — grant-date fair value by award type

Named executive officerTime-vested (RSU)Performance-vested (PSU)Options / SARs% performance-vested
Johanna Mercier$1,299,859$0$1,299,9760.0%
Andrew Dickinson1,299,85901,299,9760.0%
Deborah Telman900,1730900,0650.0%
Dietmar Berger5,499,62401,000,0430.0%
Daniel O'Day4,500,27804,500,0600.0%

% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.

04

Outstanding equity awards at fiscal year-end 2025

ExecutiveAwardShares unvestedExercise priceMarket value unvested
Daniel O'DayRSU38,396—$4,712,725
Daniel O'DayPSU58,550—7,186,427
Dietmar BergerRSU8,530—1,046,972
Andrew DickinsonRSU7,787—955,752
Johanna MercierRSU10,178—1,249,207
Andrew DickinsonRSU10,176—1,248,991
Dietmar BergerOption37,710117.21—
Johanna MercierRSU1,740—213,568
Andrew DickinsonRSU1,592—195,402
Andrew DickinsonRSU29,670—3,641,696
Johanna MercierPSU18,450—2,264,553
Johanna MercierRSU11,090—1,361,187
Johanna MercierRSU7,358—903,060
Johanna MercierRSU9,734—1,194,751
Johanna MercierPSU7,440—913,186
Johanna MercierRSU7,432—912,157
Andrew DickinsonRSU5,110—627,201
Johanna MercierRSU5,110—627,201
Johanna MercierRSU9,615—1,180,132
Daniel O'DayRSU24,709—3,032,789
Dietmar BergerPSU5,725—702,687
Daniel O'DayRSU14,741—1,809,310
Daniel O'DayPSU25,755—3,161,169
Andrew DickinsonRSU7,432—912,157
Johanna MercierRSU7,787—955,752
Dietmar BergerRSU48,975—6,011,192
Johanna MercierRSU29,670—3,641,696
Andrew DickinsonRSU9,615—1,180,132
Daniel O'DayRSU85,580—10,504,089
Daniel O'DayRSU38,395—4,712,602
Daniel O'DayRSU32,292—3,963,510
Daniel O'DayRSU30,887—3,791,070
Daniel O'DayRSU27,739—3,404,626
Daniel O'DayOption169,690117.21—
Daniel O'DayRSU21,441—2,631,699
Daniel O'DayRSU21,226—2,605,285
Andrew DickinsonRSU11,090—1,361,187
Andrew DickinsonRSU9,734—1,194,751
Andrew DickinsonPSU7,440—913,186
Andrew DickinsonRSU7,358—903,060
Daniel O'DayOption157,01175.12—
Johanna MercierOption49,48375.12—
Daniel O'DayOption67,21879.5—
Andrew DickinsonOption49,48375.12—
Daniel O'DayOption24,95357.92—
Andrew DickinsonOption23,30279.5—
Johanna MercierOption23,30279.5—
Andrew DickinsonOption49,020117.21—
Johanna MercierOption49,020117.21—
Andrew DickinsonOption9,81557.92—
Johanna MercierOption10,73057.92—
Daniel O'DayRSU4,047—496,729
Andrew DickinsonPSU18,450—2,264,553
05

Incentive-plan design — the Compensation Discussion & Analysis

Our executive compensation program is built on the following fundamental principles that we believe are imperative to achieving our mission while also balancing the long-term interests of our stockholders: Pay-for-Performance, Short- and Long-Term Balance, Value Optimization, Market Competitiveness, Stockholder Alignment

CEO STI target (% of salary)150%
CEO LTI target (% of salary)—
Independent consultantFW Cook
Clawback policytrue
Anti-hedgingtrue
Anti-pledgingTrue
06

Say-on-pay — recent advisory votes

Meeting yearMeeting dateForAgainstAbstainSupportOutcome
20262026-04-30954,325,80577,503,9473,342,32592.19%Passed
20252025-05-07929,612,73989,351,5012,415,14691.23%Passed
20242024-05-08928,702,91578,647,8081,814,60192.19%Passed
20232023-05-03919,145,38279,500,1053,262,91692.04%Passed
20222022-05-04875,824,76274,354,0692,175,53392.17%Passed
20212021-05-12811,920,486120,448,1882,298,93887.08%Passed

Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.

Say-on-pay — history, company's computation

Meeting yearMeeting dateApproval — company's computation
20262026-04-3092.19%a
20252025-05-0791.23%b
20242024-05-0892.19%c

a. Approved under the standard stated in the filing — “With respect to Proposal 1, abstentions will have no effect on the outcome of the vote. With respect to Proposals 2-7, abstentions will have the same effect as an "against" vote.”.

b. Approved under the standard stated in the filing — “With respect to Proposal 1, abstentions will have no effect on the outcome of the vote.”.

c. Approved under the standard stated in the filing — “This is known as a "broker non-vote." With respect to Proposal 1, abstentions will have no effect on the outcome of the vote.”.

Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.

07

CEO pay ratio

Ratio (CEO : median employee)119 : 1
CEO total compensation$28,437,198
Median employee compensation$238,979
08

Director compensation — fiscal year 2025

DirectorCash feesStock awardsOption awardsNon-equity incentiveAll otherTotal
Anthony WeltersIndependent · Lead Independent Director · Compensation and Talent (Chair) · Nominating and Corporate Governance$180,041$149,932$149,989$0—$479,962
Kelly A. KramerIndependent · Audit (Chair) · Compensation and Talent137,521149,932149,9890—437,442
Sandra J. HorningIndependent · Nominating and Corporate Governance · Science (Chair)132,521149,932149,98901,500433,942
Harish M. ManwaniIndependent · Compensation and Talent · Nominating and Corporate Governance (Chair)132,521149,932149,9890—432,442
Jacqueline K. BartonIndependent · Compensation and Talent · Science115,000149,932149,989015,000429,921
Ted W. LoveIndependent · Audit · Science95,000149,932149,989015,000409,921
Javier J. RodriguezIndependent · Audit · Nominating and Corporate Governance95,000149,932149,989015,000409,921
Jeffrey A. BluestoneIndependent · Nominating and Corporate Governance · Science95,000149,932149,989014,860409,781
Daniel P. O'DayEmployee director000—00
09

Board fee structure and ownership guideline

Annual cash retainer$75,000
Annual equity retainer$300,000
Per board meeting fee—
Committee chair fees (audit / comp / nom-gov)—
Stock ownership guideline5x annual cash retainer
09b

Total cost of the board

ComponentFY2025
Cash retainers and fees$982,604
Equity awards (grant-date value)$1,199,456
All other compensation$61,360
Total cost of the board$2,243,420

Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.

10

Disclosed peer group — fiscal year 2025

The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.

10a

Peer reciprocity

Of the companies GILEAD SCIENCES, INC. names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.

Reciprocity shown where the peer's own current proxy has been read — each mark is cited in the register to that peer's filing. A dash means the peer's current proxy was read and names no reciprocal group including GILEAD SCIENCES, INC..

10b

Chief executive pay against the peer group

Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.

RankCompanyFYChief executiveSalaryStock awardsOption awardsNon-equity incentiveTotal
1Eli Lilly and Company2025David Ricks$1,700,000$23,325,000$0$6,485,500$36,698,337
2Johnson & Johnson2025Joaquin Duato1,600,00015,028,9485,927,9954,298,70032,758,111
3AbbVie Inc.2025Robert Michael1,700,00013,268,4563,199,1545,200,00032,530,984
4GILEAD SCIENCES, INC.2025Daniel O'Day1,795,19215,238,4024,500,0604,848,12028,437,198
5Pfizer Inc.2025Albert Bourla1,800,0009,442,7058,998,1415,400,00027,585,301
6Amgen Inc.2025Robert Bradway1,925,40912,599,5895,399,9963,907,00024,693,120
7Biogen Inc.2025Christopher Viehbacher1,727,88518,368,87503,190,87523,646,004
8Bristol Myers Squibb Company2025Christopher Boerner1,586,34616,061,39903,754,68421,879,919
9Vertex Pharmaceuticals Incorporated2025Reshma Kewalramani1,600,00015,002,27004,118,64021,144,261
10Merck & Co., Inc.2025Robert Davis1,645,30212,102,8383,380,0042,326,50020,797,845
11Regeneron Pharmaceuticals, Inc.2025Leonard Schleifer1,979,922003,682,6557,280,549

Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.

10c

Incentive design against the same peers

CompanyAnnual incentive payoutLong-term vehicle mixPSU measures include TSRCompensation consultant
GILEAD SCIENCES, INC.180%PSU 50 · Options 25 · RSU 25Yes — Relative TSRFW Cook
AbbVie Inc.not disclosedPSU 40 · PRSU 40 · Option 20Yes — Relative TSRSemler Brossy
Amgen Inc.136.0%PSU 50 · Options 30 · RSU 20Yes — relative TSRFrederic W. Cook & Co., Inc. (FW Cook)
Biogen Inc.127%PSU 60 · RSU 40YesPay Governance
Bristol Myers Squibb Company157.66%PSU 60 · MSU 40Yes — 3-Year Relative TSR CAGRFarient Advisors LLC
Eli Lilly and Company218%PSU 100NoFW Cook
Johnson & Johnsonnot disclosednot disclosedYes — Relative TSRSemler Brossy Consulting Group
Merck & Co., Inc.94%PSU 60 · RSU 20 · Options 20Yes — Relative Total Shareholder Return (R-TSR)FW Cook
Pfizer Inc.150%PSU 50 · MSU 50Yes — relative TSR as compared to the NYSE Arca Pharmaceutical Index (DRG Index or DRG)Meridian Compensation Partners, LLC
Regeneron Pharmaceuticals, Inc.155%Options 60 · RSU 40not disclosedPay Governance LLC
Vertex Pharmaceuticals Incorporatednot disclosedPSU 55 · RSU 45Nonot disclosed

Read from each company's Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company's filing does not state the item.

10d

Frequently asked questions

Who was the highest-paid executive at GILEAD SCIENCES, INC. in fiscal 2025?
As disclosed, Daniel O'Day (Chairman and Chief Executive Officer) was the highest-paid executive at GILEAD SCIENCES, INC. in fiscal 2025, with total compensation of $28,437,198.
How does GILEAD SCIENCES, INC.'s chief executive pay compare to its disclosed peer group?
As disclosed, Daniel O'Day's total compensation ranked at the 70th percentile of GILEAD SCIENCES, INC.'s disclosed peer group.
What is GILEAD SCIENCES, INC.'s CEO-to-median employee pay ratio?
As disclosed, GILEAD SCIENCES, INC.'s CEO-to-median employee pay ratio was 119:1.
How did shareholders vote on GILEAD SCIENCES, INC.'s executive compensation?
As disclosed, 92.19% of shareholders supported GILEAD SCIENCES, INC.'s executive compensation in the latest say-on-pay vote.
How much does GILEAD SCIENCES, INC. spend in total on board compensation for fiscal 2025?
As disclosed, GILEAD SCIENCES, INC. reported total board compensation of $2,243,420 for fiscal 2025.

Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.

11

Source register

Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.

#SupportsDocumentFiledAccessionLocation in document
1Section 01, Daniel O'DayDEF 14A2026-03-200001308179-26-000106Section “Summary Compensation Table” · page 74. As printed: 28,437,198. Filing ↗machine: t414 · r1 · c29 · span 989582–989592
2Section 01, Dietmar BergerDEF 14A2026-03-200001308179-26-000106Section “Summary Compensation Table” · page 74. As printed: 13,922,878. Filing ↗machine: span 1025472–1025482
3Section 01, Johanna MercierDEF 14A2026-03-200001308179-26-000106Section “Summary Compensation Table” · page 74. As printed: 9,300,643. Filing ↗machine: r7 · c28 · span 1013633–1013642
4Section 01, Andrew DickinsonDEF 14A2026-03-200001308179-26-000106Section “Summary Compensation Table” · page 74. As printed: 8,765,616. Filing ↗machine: r4 · c28 · span 1001036–1001045
5Section 01, Deborah TelmanDEF 14A2026-03-200001308179-26-000106Section “Summary Compensation Table” · page 74. As printed: 5,004,669. Filing ↗machine: r11 · c28 · span 1029136–1029145
6Section 03, Johanna Mercier Performance ShareDEF 14A2026-03-200001308179-26-000106Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t424 · r15 · c45 · span 1155843–1155850
7Section 03, Andrew Dickinson Performance ShareDEF 14A2026-03-200001308179-26-000106Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t424 · r8 · c45 · span 1107790–1107797
8Section 03, Johanna Mercier Performance ShareDEF 14A2026-03-200001308179-26-000106Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t424 · r16 · c45 · span 1161480–1161489
9Section 03, Deborah Telman Performance ShareDEF 14A2026-03-200001308179-26-000106Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t424 · r25 · c45 · span 1220367–1220374
10Section 03, Deborah Telman Performance ShareDEF 14A2026-03-200001308179-26-000106Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t424 · r26 · c45 · span 1226000–1226007
11Section 03, Dietmar Berger Performance ShareDEF 14A2026-03-200001308179-26-000106Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t424 · r20 · c45 · span 1185851–1185860
12Section 03, Dietmar Berger RSUDEF 14A2026-03-200001308179-26-000106Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t439 · r21 · c12 · span 1420420–1420425
13Section 03, Deborah Telman Performance ShareDEF 14A2026-03-200001308179-26-000106Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t424 · r27 · c45 · span 1231636–1231645
14Section 03, Deborah Telman RSUDEF 14A2026-03-200001308179-26-000106Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t424 · r29 · c45 · span 1242975–1242982
15Section 03, Daniel O'Day Performance ShareDEF 14A2026-03-200001308179-26-000106Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t424 · r3 · c44 · span 1078272–1078281
16Section 03, Dietmar Berger OPTIONDEF 14A2026-03-200001308179-26-000106Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t409 · r4 · c4 · span 973499–973505
17Section 03, Johanna Mercier Performance ShareDEF 14A2026-03-200001308179-26-000106Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t424 · r14 · c45 · span 1150207–1150214
18Section 03, Johanna Mercier OPTIONDEF 14A2026-03-200001308179-26-000106Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t409 · r3 · c4 · span 970050–970056
19Section 03, Andrew Dickinson Performance ShareDEF 14A2026-03-200001308179-26-000106Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t424 · r10 · c45 · span 1122447–1122456
20Section 03, Dietmar Berger RSUDEF 14A2026-03-200001308179-26-000106Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t439 · r23 · c13 · span 1427453–1427459
21Section 03, Andrew Dickinson Performance ShareDEF 14A2026-03-200001308179-26-000106Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t424 · r9 · c45 · span 1115118–1115125
22Section 03, Johanna Mercier RSUDEF 14A2026-03-200001308179-26-000106Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t439 · r15 · c13 · span 1403918–1403924
23Section 03, Daniel O'Day Performance ShareDEF 14A2026-03-200001308179-26-000106Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t424 · r4 · c44 · span 1083813–1083822
24Section 03, Daniel O'Day RSUDEF 14A2026-03-200001308179-26-000106Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t424 · r6 · c44 · span 1094895–1094904
25Section 03, Andrew Dickinson RSUDEF 14A2026-03-200001308179-26-000106Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t424 · r12 · c45 · span 1137108–1137117
26Section 03, Daniel O'Day Performance ShareDEF 14A2026-03-200001308179-26-000106Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t424 · r2 · c45 · span 1072720–1072729
27Section 03, Andrew Dickinson OPTIONDEF 14A2026-03-200001308179-26-000106Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t409 · r2 · c4 · span 966851–966857
28Section 03, Deborah Telman OPTIONDEF 14A2026-03-200001308179-26-000106Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t409 · r5 · c4 · span 976670–976676
29Section 03, Daniel O'Day OPTIONDEF 14A2026-03-200001308179-26-000106Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t409 · r1 · c4 · span 963281–963288
30Section 07, pay ratioDEF 14A2026-03-200001308179-26-000106Section “CEO Pay Ratio”. As printed: 119 : 1. Filing ↗machine: span 954130–954138
31Section 08, Anthony WeltersDEF 14A2026-03-200001308179-26-000106Section “Director Compensation”. As printed: 479,962. Filing ↗machine: t249 · r8 · c19 · span 648004–648011
32Section 08, Kelly A. KramerDEF 14A2026-03-200001308179-26-000106Section “Director Compensation”. As printed: 437,442. Filing ↗machine: t249 · r4 · c19 · span 640806–640813
33Section 08, Sandra J. HorningDEF 14A2026-03-200001308179-26-000106Section “Director Compensation”. As printed: 433,942. Filing ↗machine: t249 · r3 · c19 · span 638999–639006
34Section 08, Harish M. ManwaniDEF 14A2026-03-200001308179-26-000106Section “Director Compensation”. As printed: 432,442. Filing ↗machine: t249 · r6 · c19 · span 644422–644429
35Section 08, Jacqueline K. BartonDEF 14A2026-03-200001308179-26-000106Section “Director Compensation”. As printed: 429,921. Filing ↗machine: t249 · r1 · c19 · span 635342–635349
36Section 08, Ted W. LoveDEF 14A2026-03-200001308179-26-000106Section “Director Compensation”. As printed: 409,921. Filing ↗machine: t249 · r5 · c19 · span 642613–642620
37Section 08, Javier J. RodriguezDEF 14A2026-03-200001308179-26-000106Section “Director Compensation”. As printed: 409,921. Filing ↗machine: t249 · r7 · c19 · span 646237–646244
38Section 08, Jeffrey A. BluestoneDEF 14A2026-03-200001308179-26-000106Section “Director Compensation”. As printed: 409,781. Filing ↗machine: t249 · r2 · c19 · span 637172–637179
39Section 08, Daniel P. O'DayDEF 14A2026-03-200001308179-26-000106Section “Director Compensation”. As printed: 0. Filing ↗
40Section 02, Daniel Patrick O'Day 2026-03-27Form 42026-03-300001638643-26-000018Insider equity transaction reported since the proxy statement. Filing ↗
41Section 02, Johanna Mercier 2026-04-15Form 42026-04-160001782135-26-000014Insider equity transaction reported since the proxy statement. Filing ↗
42Section 02, Andrew Dickinson 2026-04-15Form 42026-04-160001310204-26-000014Insider equity transaction reported since the proxy statement. Filing ↗
43Section 02, Daniel Patrick O'Day 2026-04-28Form 42026-04-290001638643-26-000020Insider equity transaction reported since the proxy statement. Filing ↗
44Section 02, Daniel Patrick O'Day 2026-04-28Form 42026-04-290001638643-26-000020Insider equity transaction reported since the proxy statement. Filing ↗
45Section 02, Harish M. Manwani 2026-04-30Form 42026-05-040001527726-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
46Section 02, Kelly A. Kramer 2026-04-30Form 42026-05-040001629885-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
47Section 02, Kelly A. Kramer 2026-04-30Form 42026-05-040001629885-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
48Section 02, Harish M. Manwani 2026-04-30Form 42026-05-040001527726-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
49Section 02, Harish M. Manwani 2026-04-30Form 42026-05-040001527726-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
50Section 02, Anthony Welters 2026-04-30Form 42026-05-040001213307-26-000003Insider equity transaction reported since the proxy statement. Filing ↗
51Section 02, Anthony Welters 2026-04-30Form 42026-05-040001213307-26-000003Insider equity transaction reported since the proxy statement. Filing ↗
52Section 02, Javier J. Rodriguez 2026-04-30Form 42026-05-040001415548-26-000003Insider equity transaction reported since the proxy statement. Filing ↗
53Section 02, Ted W. Love 2026-04-30Form 42026-05-040001188919-26-000004Insider equity transaction reported since the proxy statement. Filing ↗
54Section 02, Sandra J. Horning 2026-04-30Form 42026-05-040001638709-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
55Section 02, Sandra J. Horning 2026-04-30Form 42026-05-040001638709-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
56Section 02, Jacqueline K. Barton 2026-04-30Form 42026-05-040001183680-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
57Section 02, Jeffrey A. Bluestone 2026-04-30Form 42026-05-040000882095-26-000010Insider equity transaction reported since the proxy statement. Filing ↗
58Section 02, Jeffrey A. Bluestone 2026-04-30Form 42026-05-040000882095-26-000010Insider equity transaction reported since the proxy statement. Filing ↗
59Section 02, Javier J. Rodriguez 2026-04-30Form 42026-05-040001415548-26-000003Insider equity transaction reported since the proxy statement. Filing ↗
60Section 02, Ted W. Love 2026-04-30Form 42026-05-040001188919-26-000004Insider equity transaction reported since the proxy statement. Filing ↗
61Section 02, Jacqueline K. Barton 2026-04-30Form 42026-05-040001183680-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
62Section 02, Johanna Mercier 2026-05-15Form 42026-05-180001782135-26-000016Insider equity transaction reported since the proxy statement. Filing ↗
63Section 02, Johanna Mercier 2026-05-15Form 42026-05-180001782135-26-000016Insider equity transaction reported since the proxy statement. Filing ↗
64Section 02, Johanna Mercier 2026-05-15Form 42026-05-180001782135-26-000016Insider equity transaction reported since the proxy statement. Filing ↗
65Section 02, Johanna Mercier 2026-05-15Form 42026-05-180001782135-26-000016Insider equity transaction reported since the proxy statement. Filing ↗
66Section 02, Johanna Mercier 2026-05-15Form 42026-05-180001782135-26-000016Insider equity transaction reported since the proxy statement. Filing ↗
67Section 02, Johanna Mercier 2026-05-15Form 42026-05-180001782135-26-000016Insider equity transaction reported since the proxy statement. Filing ↗
68Section 02, Andrew Dickinson 2026-05-15Form 42026-05-180001310204-26-000016Insider equity transaction reported since the proxy statement. Filing ↗
69Section 02, Daniel Patrick O'Day 2026-06-01Form 42026-06-020001638643-26-000022Insider equity transaction reported since the proxy statement. Filing ↗
70Section 02, Daniel Patrick O'Day 2026-06-01Form 42026-06-020001638643-26-000022Insider equity transaction reported since the proxy statement. Filing ↗
71Section 02, Daniel Patrick O'Day 2026-06-01Form 42026-06-020001638643-26-000022Insider equity transaction reported since the proxy statement. Filing ↗
72Section 02, Daniel Patrick O'Day 2026-06-10Form 42026-06-110001638643-26-000024Insider equity transaction reported since the proxy statement. Filing ↗
73Section 02, Daniel Patrick O'Day 2026-06-10Form 42026-06-110001638643-26-000024Insider equity transaction reported since the proxy statement. Filing ↗
74Section 02, Daniel Patrick O'Day 2026-06-10Form 42026-06-110001638643-26-000024Insider equity transaction reported since the proxy statement. Filing ↗
75Section 02, Johanna Mercier 2026-06-10Form 42026-06-110001782135-26-000022Insider equity transaction reported since the proxy statement. Filing ↗
76Section 02, Andrew Dickinson 2026-06-10Form 42026-06-110001310204-26-000018Insider equity transaction reported since the proxy statement. Filing ↗
77Section 02, Andrew Dickinson 2026-06-10Form 42026-06-110001310204-26-000018Insider equity transaction reported since the proxy statement. Filing ↗
78Section 02, Cain Wettan Keeley M 2026-06-10Form 42026-06-110002110603-26-000008Insider equity transaction reported since the proxy statement. Filing ↗
79Section 02, Cain Wettan Keeley M 2026-06-10Form 42026-06-110002110603-26-000008Insider equity transaction reported since the proxy statement. Filing ↗
80Section 02, Dietmar Berger 2026-06-10Form 42026-06-110001739515-26-000008Insider equity transaction reported since the proxy statement. Filing ↗
81Section 02, Dietmar Berger 2026-06-10Form 42026-06-110001739515-26-000008Insider equity transaction reported since the proxy statement. Filing ↗
82Section 02, Dietmar Berger 2026-06-10Form 42026-06-110001739515-26-000008Insider equity transaction reported since the proxy statement. Filing ↗
83Section 02, Johanna Mercier 2026-06-10Form 42026-06-110001782135-26-000022Insider equity transaction reported since the proxy statement. Filing ↗
84Section 02, Andrew Dickinson 2026-06-10Form 42026-06-110001310204-26-000018Insider equity transaction reported since the proxy statement. Filing ↗
85Section 02, Cain Wettan Keeley M 2026-06-10Form 42026-06-110002110603-26-000008Insider equity transaction reported since the proxy statement. Filing ↗
86Section 02, Johanna Mercier 2026-06-10Form 42026-06-110001782135-26-000022Insider equity transaction reported since the proxy statement. Filing ↗
87Section 02, Andrew Dickinson 2026-06-15Form 42026-06-160001310204-26-000020Insider equity transaction reported since the proxy statement. Filing ↗
88Section 02, Johanna Mercier 2026-06-15Form 42026-06-160001782135-26-000024Insider equity transaction reported since the proxy statement. Filing ↗
89Section 02, Johanna Mercier 2026-06-15Form 42026-06-160001782135-26-000024Insider equity transaction reported since the proxy statement. Filing ↗
90Section 02, Johanna Mercier 2026-06-15Form 42026-06-160001782135-26-000024Insider equity transaction reported since the proxy statement. Filing ↗
91Section 02, Daniel Patrick O'Day 2026-07-01Form 42026-07-020001638643-26-000026Insider equity transaction reported since the proxy statement. Filing ↗
92Section 02, Daniel Patrick O'Day 2026-07-01Form 42026-07-020001638643-26-000026Insider equity transaction reported since the proxy statement. Filing ↗
93Section 02, Johanna Mercier 2026-07-15Form 42026-07-160001782135-26-000026Insider equity transaction reported since the proxy statement. Filing ↗
94Section 02, Andrew Dickinson 2026-07-15Form 42026-07-160001310204-26-000022Insider equity transaction reported since the proxy statement. Filing ↗
95Section 02, Daniel Patrick O'Day 2026-08-03Form 42026-08-040001638643-26-000028Insider equity transaction reported since the proxy statement. Filing ↗
96Section 02, Daniel Patrick O'Day 2026-08-03Form 42026-08-040001638643-26-000028Insider equity transaction reported since the proxy statement. Filing ↗
97Section 02, Daniel Patrick O'Day 2026-08-03Form 42026-08-040001638643-26-000028Insider equity transaction reported since the proxy statement. Filing ↗
98Section 02, Cain Wettan Keeley M 2026-08-10Form 42026-08-110002110603-26-000010Insider equity transaction reported since the proxy statement. Filing ↗
99Section 02, Cain Wettan Keeley M 2026-08-10Form 42026-08-110002110603-26-000010Insider equity transaction reported since the proxy statement. Filing ↗
100Section 02, Cain Wettan Keeley M 2026-08-10Form 42026-08-110002110603-26-000010Insider equity transaction reported since the proxy statement. Filing ↗
101Section 02, Johanna Mercier 2026-08-17Form 42026-08-180001782135-26-000028Insider equity transaction reported since the proxy statement. Filing ↗
102Section 02, Johanna Mercier 2026-08-17Form 42026-08-180001782135-26-000028Insider equity transaction reported since the proxy statement. Filing ↗
103Section 02, Johanna Mercier 2026-08-17Form 42026-08-180001782135-26-000028Insider equity transaction reported since the proxy statement. Filing ↗
104Section 02, Johanna Mercier 2026-08-17Form 42026-08-180001782135-26-000028Insider equity transaction reported since the proxy statement. Filing ↗
105Section 02, Andrew Dickinson 2026-08-17Form 42026-08-180001310204-26-000024Insider equity transaction reported since the proxy statement. Filing ↗
106Section 02, Johanna Mercier 2026-08-17Form 42026-08-180001782135-26-000028Insider equity transaction reported since the proxy statement. Filing ↗
107Section 02, Johanna Mercier 2026-08-17Form 42026-08-180001782135-26-000028Insider equity transaction reported since the proxy statement. Filing ↗
108Section 02, Jeffrey A. Bluestone 2026-08-20Form 42026-08-210001771814-26-000005Insider equity transaction reported since the proxy statement. Filing ↗
109Section 02, Jeffrey A. Bluestone 2026-08-20Form 42026-08-210001771814-26-000005Insider equity transaction reported since the proxy statement. Filing ↗
110Section 02, Jeffrey A. Bluestone 2026-08-20Form 42026-08-210001771814-26-000005Insider equity transaction reported since the proxy statement. Filing ↗
111Section 02, Jeffrey A. Bluestone 2026-08-20Form 42026-08-210001771814-26-000005Insider equity transaction reported since the proxy statement. Filing ↗
112Section 02, Jeffrey A. Bluestone 2026-08-20Form 42026-08-210001771814-26-000005Insider equity transaction reported since the proxy statement. Filing ↗
113Section 02, Jeffrey A. Bluestone 2026-08-20Form 42026-08-210001771814-26-000005Insider equity transaction reported since the proxy statement. Filing ↗
114Section 02, Jeffrey A. Bluestone 2026-08-20Form 42026-08-210001771814-26-000005Insider equity transaction reported since the proxy statement. Filing ↗
115Section 02, Jeffrey A. Bluestone 2026-08-20Form 42026-08-210001771814-26-000005Insider equity transaction reported since the proxy statement. Filing ↗
116Section 02, Jeffrey A. Bluestone 2026-08-20Form 42026-08-210001771814-26-000005Insider equity transaction reported since the proxy statement. Filing ↗
117Section 02, Jeffrey A. Bluestone 2026-08-20Form 42026-08-210001771814-26-000005Insider equity transaction reported since the proxy statement. Filing ↗
118Section 02, Jeffrey A. Bluestone 2026-08-20Form 42026-08-210001771814-26-000005Insider equity transaction reported since the proxy statement. Filing ↗
119Section 02, Jeffrey A. Bluestone 2026-08-20Form 42026-08-210001771814-26-000005Insider equity transaction reported since the proxy statement. Filing ↗
120Section 02, Anthony Welters 2026-08-26Form 42026-08-270001213307-26-000005Insider equity transaction reported since the proxy statement. Filing ↗
121Section 02, Anthony Welters 2026-08-26Form 42026-08-270001213307-26-000005Insider equity transaction reported since the proxy statement. Filing ↗
122Section 02, Anthony Welters 2026-08-26Form 42026-08-270001213307-26-000005Insider equity transaction reported since the proxy statement. Filing ↗
123Section 02, Anthony Welters 2026-08-26Form 42026-08-270001213307-26-000005Insider equity transaction reported since the proxy statement. Filing ↗
124Section 02, Anthony Welters 2026-08-26Form 42026-08-270001213307-26-000005Insider equity transaction reported since the proxy statement. Filing ↗
125Section 02, Anthony Welters 2026-08-26Form 42026-08-270001213307-26-000005Insider equity transaction reported since the proxy statement. Filing ↗
126Section 02, Anthony Welters 2026-08-26Form 42026-08-270001213307-26-000005Insider equity transaction reported since the proxy statement. Filing ↗
127Section 02, Anthony Welters 2026-08-26Form 42026-08-270001213307-26-000005Insider equity transaction reported since the proxy statement. Filing ↗
128Section 02, Daniel Patrick O'Day 2026-09-01Form 42026-09-020001638643-26-000031Insider equity transaction reported since the proxy statement. Filing ↗
129Section 02, Daniel Patrick O'Day 2026-09-01Form 42026-09-020001638643-26-000031Insider equity transaction reported since the proxy statement. Filing ↗
130Section 02, Daniel Patrick O'Day 2026-09-01Form 42026-09-020001638643-26-000031Insider equity transaction reported since the proxy statement. Filing ↗
131Section 02, Daniel Patrick O'Day 2026-09-10Form 42026-09-110001638643-26-000033Insider equity transaction reported since the proxy statement. Filing ↗
132Section 02, Daniel Patrick O'Day 2026-09-10Form 42026-09-110001638643-26-000033Insider equity transaction reported since the proxy statement. Filing ↗
133Section 02, Daniel Patrick O'Day 2026-09-10Form 42026-09-110001638643-26-000033Insider equity transaction reported since the proxy statement. Filing ↗
134Section 02, Cain Wettan Keeley M 2026-09-10Form 42026-09-110002110603-26-000013Insider equity transaction reported since the proxy statement. Filing ↗
135Section 02, Cain Wettan Keeley M 2026-09-10Form 42026-09-110002110603-26-000013Insider equity transaction reported since the proxy statement. Filing ↗
136Section 02, Johanna Mercier 2026-09-10Form 42026-09-110001782135-26-000031Insider equity transaction reported since the proxy statement. Filing ↗
137Section 02, Johanna Mercier 2026-09-10Form 42026-09-110001782135-26-000031Insider equity transaction reported since the proxy statement. Filing ↗
138Section 02, Johanna Mercier 2026-09-10Form 42026-09-110001782135-26-000031Insider equity transaction reported since the proxy statement. Filing ↗
139Section 02, Dietmar Berger 2026-09-10Form 42026-09-110001739515-26-000011Insider equity transaction reported since the proxy statement. Filing ↗
140Section 02, Dietmar Berger 2026-09-10Form 42026-09-110001739515-26-000011Insider equity transaction reported since the proxy statement. Filing ↗
141Section 02, Andrew Dickinson 2026-09-10Form 42026-09-110001310204-26-000027Insider equity transaction reported since the proxy statement. Filing ↗
142Section 02, Dietmar Berger 2026-09-10Form 42026-09-110001739515-26-000011Insider equity transaction reported since the proxy statement. Filing ↗
143Section 02, Andrew Dickinson 2026-09-10Form 42026-09-110001310204-26-000027Insider equity transaction reported since the proxy statement. Filing ↗
144Section 02, Andrew Dickinson 2026-09-10Form 42026-09-110001310204-26-000027Insider equity transaction reported since the proxy statement. Filing ↗
145Section 02, Cain Wettan Keeley M 2026-09-10Form 42026-09-110002110603-26-000013Insider equity transaction reported since the proxy statement. Filing ↗
146Section 02, Johanna Mercier 2026-09-15Form 42026-09-160001782135-26-000033Insider equity transaction reported since the proxy statement. Filing ↗
147Section 02, Johanna Mercier 2026-09-15Form 42026-09-160001782135-26-000033Insider equity transaction reported since the proxy statement. Filing ↗
148Section 02, Andrew Dickinson 2026-09-15Form 42026-09-160001310204-26-000029Insider equity transaction reported since the proxy statement. Filing ↗
149Section 02, Johanna Mercier 2026-09-15Form 42026-09-160001782135-26-000033Insider equity transaction reported since the proxy statement. Filing ↗
150Section 02, Erin Burkhart 2026-09-22Form 42026-09-230001927648-26-000005Insider equity transaction reported since the proxy statement. Filing ↗
151Section 02, Erin Burkhart 2026-09-22Form 42026-09-230001927648-26-000005Insider equity transaction reported since the proxy statement. Filing ↗
152Section 02, Erin Burkhart 2026-09-22Form 42026-09-230001927648-26-000005Insider equity transaction reported since the proxy statement. Filing ↗
153Section 02, Daniel Patrick O'Day 2026-10-01Form 42026-10-020001638643-26-000035Insider equity transaction reported since the proxy statement. Filing ↗
154Section 02, Daniel Patrick O'Day 2026-10-01Form 42026-10-020001638643-26-000035Insider equity transaction reported since the proxy statement. Filing ↗
155Section 02, Andrew Dickinson 2026-10-15Form 42026-10-160001310204-26-000031Insider equity transaction reported since the proxy statement. Filing ↗
156Section 02, Johanna Mercier 2026-10-15Form 42026-10-160001782135-26-000035Insider equity transaction reported since the proxy statement. Filing ↗
157Section 06, 2026 voteForm 8-K2026-05-040000882095-26-000008Item 5.07 · say-on-pay result. As reported: 92.19% (votes for as printed: 954,325,805). Filing ↗
158Section 06, 2025 voteForm 8-K2025-05-080000882095-25-000015Item 5.07 · say-on-pay result. As reported: 91.23% (votes for as printed: 929,612,739). Filing ↗
159Section 06, 2024 voteForm 8-K2024-05-090000882095-24-000016Item 5.07 · say-on-pay result. As reported: 92.19% (votes for as printed: 928,702,915). Filing ↗
160Section 01 trend, Δ column (computed)Computed——Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1)
161Section 03b vehicle mix (computed)Computed——RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio
162Section 09b board cost (computed)Computed——Cash 982,604 + equity 1,199,456 + all other 61,360 = 2,243,420, summed across the director compensation table rows.machine: formula: Σ = 2,243,420
163Eli Lilly and Company, Section 10b CEO totalDEF 14A2026-03-200000059478-26-000029CEO total compensation as printed in Eli Lilly and Company's own proxy. As printed: 36,698,337. Filing ↗machine: t92 · r2 · c20 · span 925013–925024
164Johnson & Johnson, Section 10b CEO totalDEF 14A2026-03-110000200406-26-000063CEO total compensation as printed in Johnson & Johnson's own proxy. As printed: 32,758,111. Filing ↗machine: r3 · c27 · span 1621235–1621246
165AbbVie Inc., Section 10b CEO totalDEF 14A2026-03-230001104659-26-033387CEO total compensation as printed in AbbVie Inc.'s own proxy. As printed: 32,530,984. Filing ↗
166GILEAD SCIENCES, INC. (subject), Section 10b CEO totalDEF 14A2026-03-200001308179-26-000106CEO total compensation as printed in GILEAD SCIENCES, INC.'s own proxy. As printed: 28,437,198. Filing ↗machine: t414 · r1 · c29 · span 989582–989592
167Pfizer Inc., Section 10b CEO totalDEF 14A2026-03-120000078003-26-000033CEO total compensation as printed in Pfizer Inc.'s own proxy. As printed: 27,585,301. Filing ↗machine: t242 · r3 · c12 · span 1506825–1506835
168Amgen Inc., Section 10b CEO totalDEF 14A2026-04-070001193125-26-145588CEO total compensation as printed in Amgen Inc.'s own proxy. As printed: 24,693,120. Filing ↗machine: span 1591156–1591166
169Biogen Inc., Section 10b CEO totalDEF 14A2026-04-280001193125-26-187303CEO total compensation as printed in Biogen Inc.'s own proxy. As printed: 23,646,004. Filing ↗machine: r2 · c16 · span 1174380–1174391
170Bristol Myers Squibb Company, Section 10b CEO totalDEF 14A2026-03-250000014272-26-000006CEO total compensation as printed in Bristol Myers Squibb Company's own proxy. As printed: 21,879,919. Filing ↗machine: t168 · r3 · c15 · span 1302160–1302170
171Vertex Pharmaceuticals Incorporated, Section 10b CEO totalDEF 14A2026-04-020000875320-26-000153CEO total compensation as printed in Vertex Pharmaceuticals Incorporated's own proxy. As printed: 21,144,261. Filing ↗machine: r2 · c13 · span 2942799–2942809
172Merck & Co., Inc., Section 10b CEO totalDEF 14A2026-04-080001193125-26-147704CEO total compensation as printed in Merck & Co., Inc.'s own proxy. As printed: 20,797,845. Filing ↗machine: span 1371012–1371022
173Regeneron Pharmaceuticals, Inc., Section 10b CEO totalDEF 14A2026-04-240001308179-26-000340CEO total compensation as printed in Regeneron Pharmaceuticals, Inc.'s own proxy. As printed: 7,280,549. Filing ↗machine: r3 · c10 · span 3335980–3335989
174Section 10a, AbbVie Inc. reciprocityDEF 14A—0001104659-26-033387AbbVie Inc. names GILEAD SCIENCES, INC. in its own disclosed peer group (read from its most recent proxy). Filing ↗
175Section 10a, Eli Lilly and Company reciprocityDEF 14A—0000059478-26-000029Eli Lilly and Company names GILEAD SCIENCES, INC. in its own disclosed peer group (read from its most recent proxy). Filing ↗
176Section 10a, Regeneron Pharmaceuticals, Inc. reciprocityDEF 14A—0001308179-26-000340Regeneron Pharmaceuticals, Inc. names GILEAD SCIENCES, INC. in its own disclosed peer group (read from its most recent proxy). Filing ↗
177Section 10a, Bristol Myers Squibb Company reciprocityDEF 14A—0000014272-26-000006Bristol Myers Squibb Company names GILEAD SCIENCES, INC. in its own disclosed peer group (read from its most recent proxy). Filing ↗
178Section 10a, Pfizer Inc. reciprocityDEF 14A—0000078003-26-000033Pfizer Inc. names GILEAD SCIENCES, INC. in its own disclosed peer group (read from its most recent proxy). Filing ↗
179Section 10a, Vertex Pharmaceuticals Incorporated reciprocityDEF 14A—0000875320-26-000153Vertex Pharmaceuticals Incorporated names GILEAD SCIENCES, INC. in its own disclosed peer group (read from its most recent proxy). Filing ↗
180Section 10a, Amgen Inc. reciprocityDEF 14A—0001193125-26-145588Amgen Inc. names GILEAD SCIENCES, INC. in its own disclosed peer group (read from its most recent proxy). Filing ↗
181Section 10a, Johnson & Johnson reciprocityDEF 14A—0000200406-26-000063Johnson & Johnson's most recent proxy was read; its disclosed peer group does not include GILEAD SCIENCES, INC.. Filing ↗
182Section 10a, Merck & Co., Inc. reciprocityDEF 14A—0001193125-26-147704Merck & Co., Inc. names GILEAD SCIENCES, INC. in its own disclosed peer group (read from its most recent proxy). Filing ↗

The Pay Desk — the free weekly executive pay briefing, one company at a time, every number traceable to a public filing.

You'll confirm on The Pay Desk's sign-up page.

Get the GILEAD SCIENCES, INC. Executive Compensation Report

$1,500

Buy the report - $1,500Both reports - $2,400
GILD Peer Teardown Report